| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/07/2010 | EP2170861A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 04/07/2010 | EP2170836A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors |
| 04/07/2010 | EP2170830A1 Compounds and methods for kinase modulation, and indications therefor |
| 04/07/2010 | EP2170827A2 Indolin-2-ones and aza-indolin-2-ones |
| 04/07/2010 | EP2170826A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 04/07/2010 | EP2170823A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 04/07/2010 | EP2170822A2 Proton acceptor iminium/carbocation-type coupling agents |
| 04/07/2010 | EP2170309A1 Methods and compositions for treating disorders |
| 04/07/2010 | EP2170065A1 Diphenyl substituted alkanes |
| 04/07/2010 | EP2170064A1 6.5-pyrrolopiperidine tachykinin receptor antagonists |
| 04/07/2010 | EP2032575B1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivative and its medical use |
| 04/07/2010 | EP1987010B1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 04/07/2010 | EP1979351B1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors |
| 04/07/2010 | EP1934214B1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/07/2010 | EP1551829B1 Novel compounds with antibacterial activity |
| 04/07/2010 | EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 04/07/2010 | CN101691368A Dehydration methylate of quinolinone alkaloid derivative and preparation method and application |
| 04/07/2010 | CN101691367A Piperazine and <2,1-a> isoquinoline compounds with antifungal activity and salts thereof |
| 04/06/2010 | US7692015 Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer |
| 04/06/2010 | US7692014 Inhibitors of the HIV integrase enzyme |
| 04/06/2010 | US7692011 8-hydroxy and 8-mercapto quinazolinones |
| 04/06/2010 | US7691892 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 04/06/2010 | US7691876 1H-pyrrolo[2,3-c]pyridine-7-carboxylic acid (4-tert-butyl-benzyl)-[2-(4-fluoro-3-trifluoromethyl-phenyl)-ethyl]-amide; cardiovascular diseases such as atherosclerosis, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemi |
| 04/06/2010 | US7691875 Imidazopyridine compounds, processes for their preparation and therapeutic uses thereof |
| 04/06/2010 | US7691868 N-{8-[2-chloro-5-(3-methylamino-prop-1-ynyl)-phenyl]-4,5-dihydro-thiazolo[4,5-h]quinazolin-2-yl}-acetamide; PI3-kinase modulators for the treatment of inflammatory or allergic diseases |
| 04/06/2010 | US7691865 4-(2-pyridin-2-yl-pyrazolo[1,5-a]pyridin-3-yl)-pyrimidin-2-ylamine; 4-[2-(6-methyl-pyridin-2-yl)-pyrazolo[1,5-a]pyrimidin-3-yl]-pyrimidin-2-ylamine; high affinity for Alk 5 and/or Alk 4 hence useful as antagonists thereof; fibrotic disorders |
| 04/06/2010 | US7691864 Anti-hypertensive composition and methods of treatment |
| 04/06/2010 | US7691860 Neuropeptide Y receptor antagonists; such as 2-(trans-4-tert-butylsulfonylaminocyclohexyl)-5-(trifluoromethyl)benzimidazole; bulimia, obesity, diabetes |
| 04/06/2010 | US7691857 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain |
| 04/06/2010 | US7691853 Pyrazole compounds useful as protein kinase inhibitors |
| 04/06/2010 | US7691846 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
| 04/06/2010 | CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives |
| 04/06/2010 | CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/06/2010 | CA2333649C Bleach catalysts and formulations containing them |
| 04/01/2010 | WO2010036998A2 Indole and indoline derivatives and methods of use thereof |
| 04/01/2010 | WO2010036632A1 Azaindazole compounds as ccr1 receptor antagonists |
| 04/01/2010 | WO2010036213A1 3-deazaneplanocin derivatives |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035723A1 Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device |
| 04/01/2010 | WO2010035589A1 Dye compound, process for producing same, and coloring agent |
| 04/01/2010 | WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035220A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035219A2 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010034799A1 3h-imidaz0 [4, 5-b] pyridine- 6 -carboxamides as anti -inflammatory agents |
| 04/01/2010 | WO2010034798A1 3h-imidazo [4, 5-c] pyridine-6-carboxamides as anti -inflammatory agents |
| 04/01/2010 | WO2010034500A1 Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists |
| 04/01/2010 | WO2010034110A1 Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists |
| 04/01/2010 | WO2009156864A3 Substituted alkyl pyrimidin-4-one derivatives |
| 04/01/2010 | WO2009156861A3 Substituted pyrimidone derivatives |
| 04/01/2010 | WO2009142842A3 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 04/01/2010 | US20100081823 Azo dyes |
| 04/01/2010 | US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter |
| 04/01/2010 | US20100081683 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes |
| 04/01/2010 | US20100081680 N-sulfonamido polycyclic pyrazolyl compounds |
| 04/01/2010 | US20100081675 Fused multicyclic compounds as protein kinase inhibitors |
| 04/01/2010 | US20100081656 Compositions and methods for modulating c-kit and pdgfr receptors |
| 04/01/2010 | US20100081654 Oncogenic-RAS-signal dependent lethal compounds |
| 04/01/2010 | US20100081652 Cinnamoyl Compound and Use Thereof |
| 04/01/2010 | US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 04/01/2010 | CA2737839A1 3h-imidazo [4, 5-c] pyridine-6-carboxamides as anti-inflammatory agents |
| 04/01/2010 | CA2737618A1 Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists |
| 04/01/2010 | CA2737552A1 3h-imidazo [4,5-b] pyridine-6-carboxamides as anti-inflammatory agents |
| 04/01/2010 | CA2737472A1 Azaindazole compounds as ccr1 receptor antagonists |
| 04/01/2010 | CA2737031A1 Indole and indoline derivatives and methods of use thereof |
| 03/31/2010 | EP2169028A2 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
| 03/31/2010 | EP2168968A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 03/31/2010 | EP2168965A1 Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists |
| 03/31/2010 | EP2168964A1 Azaindole-indole coupled derivatives, preparation methods and uses thereof |
| 03/31/2010 | EP2167504A2 Thiadiazole modulators of pkb |
| 03/31/2010 | EP2167494A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 03/31/2010 | EP2167471A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 03/31/2010 | EP2167470A1 Triazolo [1, 5-a]quinolines as adenosine a3 receptor ligands |
| 03/31/2010 | EP2167466A1 N-phenyl hydrazides as modulators of the ghrelin receptor |
| 03/31/2010 | EP2167465A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 03/31/2010 | EP2167196A1 Heterocyclic compounds for the treatment of tuberculosis |
| 03/31/2010 | EP2167092A2 Quinazoline derivatives as pi3 kinase inhibitors |
| 03/31/2010 | EP2166856A1 Chemical compounds |
| 03/31/2010 | EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions |
| 03/31/2010 | EP2166853A1 Therapeutic pyrazolonaphthyridine derivatives |
| 03/31/2010 | EP2166852A1 Therapeutic pyrazoloquinoline derivatives |
| 03/31/2010 | EP1786814B1 Bicyclononene derivatives as renin inhibitors |
| 03/31/2010 | EP1735311B1 Beta-carbolines useful for treating inflammatory disease |
| 03/31/2010 | EP1620091B1 Inhibitors of glutaminyl cyclase |
| 03/31/2010 | CN101687887A Tricyclic nitrogen containing compounds as antibacterial agents |
| 03/31/2010 | CN101687871A Spiro condensed barbituric acid derivatives for use as antibacterial |
| 03/31/2010 | CN101687870A Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments |
| 03/31/2010 | CN101687869A Heterocyclic compounds useful as MK2 inhibitors |
| 03/31/2010 | CN101687868A morphinan compounds |
| 03/31/2010 | CN101687867A imidazoquinolines with immuno-modulating properties |
| 03/31/2010 | CN101687866A Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| 03/31/2010 | CN101687865A A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
| 03/31/2010 | CN101687864A 1-cyanocyclopropyl-derivatives as cathepsin K inhibitors |
| 03/31/2010 | CN101687841A Benzimidazole derivatives |
| 03/31/2010 | CN101687815A a regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| 03/31/2010 | CN101687796A Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 03/31/2010 | CN101687792A Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 03/31/2010 | CN101687763A Photocrosslinkable materials comprising alicyclic group |
| 03/31/2010 | CN101686967A Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 03/31/2010 | CN101684119A 5,8-disubstituted-1,6-quinazoline-7-amidocarbonylation compound, preparing method, composite and application thereof |